1. Rothrock SG, Pagane J. Acute appendicitis in children: emergency department diagnosis and management. Ann Emerg Med. 2000;36(1):39–51.
2. Snyder BK, Hayden SR. Accuracy of leukocyte count in the diagnosis of acute appendicitis. Ann Emerg Med. 1999;33:565–74.
3. Paulson EK, Kalady MF, Pappas TN. Clinical practice. Suspected appendicitis. N Engl J Med. 2003;348:236–42.
4. Gronroos JM, Gronroos P. Leucocyte count and C-reactive protein in the diagnosis of acute appendicitis. Br J Surg. 1999;86:501–4.
5. Bouchon A, Dietrich J, Colonna M. Cutting Edge: Inflammatory response can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;15(10):164. 4991–5.
6. Van Bremen T, Dromann D, Luitjens K, Dodt C, Dalhoff K, Goldmann T, Schaaf B. Triggering receptor expressed on myeloid cells-1 (TREM-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsis. Diagn Pathol. 2013;8:24–31.
7. Wu y, Wanf F, Fan X, Bao R, Bo L, Li J, Deng X. Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: A systematic review and meta-analysis. Crit Care. 2012;16:R229.
8. Zhang J, She D, Fend, Jia Y, Xie L. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: A prospective study. BMC Infect Dis. 2011;11:53–9.
9. Jeong SJ, Song YG, Kim CO, Kim HW, Ku NS, Han SH, Choi JY, Kim JM. Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness. Shock. 2012;37(6):574–8.
10. Dai X, Zeng Z, Fu C, Zhang S, Cai Y, Chen Z. Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on the myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury. Crit Care. 2015;6(19(1):223–33.
11. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004;29(350(5):451–8.
12. Ramirez P, Kot P, Marti V, Gomez MD, Martinez, Saiz V, Catala F, Bonastre J, Menendez R.. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: A preliminary observational study. Crit Care. 2011;15(1):R50.
13. Determann RM, Schultz MJ, Geerlings SE. Soluble triggering receptor expressed on myeloid cells-1 is not a sufficient biological marker for infection of the urinary tract. J Infect. 2007;54(6):e249-50.
14. Determann RM, Weisfelt M, de Gans J, van der Ende A, Schultz MJ, van de Beek D. Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis. Intensive Care Med. 2006;32(8):1243–7.
15. Bellos I, Fitrou G, Daskalakis G, Thomakos N, Papantoniou N, Pergialiotis V. Soluble TREM-1 as a predictive factor of neonatal sepsis: a meta-analysis. Inflamm Res. 2018;67(7):571–8.
16. Tunç T, Polat A, Özdemir R, Kiliçaslan B, Can E, Çelik HT, Arsan S, Kader Ş, Erol S, Uslu S, Özdemir ÖMA, neonatal sepsis study group Neonatal sepsis study group: B. Özcan, Hanta D, Dilli D, Narter F, Gültekin N, Güzoğlu N, Aydemir Ö. Assessment of novel biomarkers: sTREM-1, pentraxin-3 and pro-adrenomedullin in the early diagnosis of neonatal early onset sepsis. J Neonatal Perinatal Med. 2019. doi:10.3233/NPM-180131. [Epub ahead of print]. Sep 28.
17. Molad Y, Pokroy-Shapira E, Kaptzan T, Monselise A, Shalita-Chesner M, Monselise Y. Serum soluble triggering receptor on myeloid cells-1 (sTREM-1) is elevated in systemic lupus erythematosus but does not distinguish between lupus alone and concurrent infection. Inflammation. 2013;36(6):1519–24.
18. Dewan S, Varma A, Talegaokar M. Increased levels of soluble triggering receptor expressed on myeloid cells sTREM1 in ICU patients with cardiovascular disease and associated organ dysfunction. Crit Care. 2011;15(Suppl1):P280.
19. Yasuda T, Takeyama Y, Ueda T, Shinzeki M, Sawa H, Takahiro N, Kamei K, Ku Y, Kuroda Y, Ohyanagi H. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Crit Care Med. 2008;36(7):2048–53.
20. Stein M, Schachter-Davidov A, Babai I, Tasher D, Somekh E. The accuracy of C-reactive protein, procalcitonin, and s-TREM-1 in the prediction of serious bacterial infection in neonates. Clin Pediatr. 2015;54(5):439–44.
21. Adly AA, Ismail EA, Andrawes NG, El-Saadany MA. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic and prognostic marker in neonatal sepsis. Cytokine. 2014;65(2):184–91.
22. Kevan EN, Simmons JR, Kocoshis SA, Cohen MB, Rudolph JA. sTREM-1 and LBP in central venous catheter-associated bloodstream infections in pediatric intestinal failure. J Pediatr Gastroenterol Nutr. 2011;53(6):627–33.
23. Schenk M, Bouchon A, Seibold F, Mueller C. TREM-1–expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest. 2007;117(10):3097–106.
24. Du C, Peng L, Kou G, Wang P, Lu L, Li Y. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome. Dig Dis Sci. 2018;63(5):1182–91.
25. https://www.equator-network.org/reporting-guidelines/stard/. Accessed November 26,2019.
26. The Harriet Lane Handbook. 2012, 19th edition, Philadephia, Elssevier Mosby.
27. Kalan M, Talbot D, Cunliffe WJ, Rich AJ. Evaluation of the modified Alvarado score in the diagnosis of acute appendicitis a prospective study. Ann R Coll Surg Engl. 1994;76:418–9.
28. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Earlbaum Associates; 1988.
29. Breiman L, Friedman J, Olshen RA, Stone CJ. Classification and Regression Trees. Monterey: Wadsworth and Brooks/Cole Advanced Books and Software; 1984.
30. Bouchon A, Facchetti F, Weigand MA, Colonna M. trem-1 amplifies inflammation and is crucial mediator of septic shock. Nature. 2001;26:410:1103–7.
31. Gibot S, Cravoisy A, Kolopp-Sarda MN, Bene MC, Faure G, Bollaert PE, Levy B. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma. Trauma. 2008;65:1385–90.
32. Gibot S, Cravoisy A, Kolopp-Sarda MN, Bene MC, Faure G, Bollaert PE, Levy B. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med. 2005;33:792–6.
33. Gorlier C, Gottenberg JE, Laurans L, Simon T, Ait-Oufella H, Sellam J. Serum level of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is a biomarker of synovitis in rheumatoid arthritis. Int J Rheum Dis. 2019;Sep;22(9):1616–8.
34. Kuemmel A, Alflen A, Schmidt LH, Sebastian M, Wiewrodt R, Schulze AB, Buhl R, Radsak M. Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancer. Sci Rep. 2018;Jul 17(1):10766. 8(.
35. Acharya A, Markar SR, Ni M, Hanna GB. Biomarkers of acute appendicitis: systematic review and cost-benefit trade-off analysis. Surg Endosc. 2017;31:1022–31.
36. Beltran MA, Almonacid J, Vicencio A, Gutierrez J, Cruces KS, Cumsille MA. Predictive value of white blood cell count and C-reactive protein in children with appendicitis. J Pediatr Surg. 2007;42:1208–14.
37. Ohle R, O'Reilly F, O'Brien KK, Fahey T, Dimitrov BD. The Alvarado score for predicting acute appendicitis: a systematic review. BMC Med. 2011;9:139–52.
38. Macco S, Vrouenraets BC, de Castro SMM. Evaluation of scoring systems in predicting acute appendicitis in children. Surgery. 2016;160:1599–604.
39. Ravichandran Y, Harrison P, Garrow E, Chao JH. Point-of-care ultrasound in pediatric appendicitis. Pediatr Emerg Care. 2016;Nov;32(11):815–6.
40. Benabbas R, Hanna M, Shah J, Sinert R. Diagnostic Accuracy of History, Physical Examination, Laboratory Tests, and Point-of-care Ultrasound for Pediatric Acute Appendicitis in the Emergency Department: A Systematic Review and Meta-analysis. Acad Emerg Med. 2017;May;24(5):523–51.